Cancer Center Support Grant View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1977-2023

FUNDING AMOUNT

383091488.0 USD

ABSTRACT

ABSTRACT Memorial Sloan Kettering Cancer Center (MSK) is a free-standing NCI-designated Comprehensive Cancer Center dedicated to improving the standards of cancer treatment, prevention and control. MSK’s research programs are grouped into three categories: Basic Research (Regulation of Cell Behavior, Developmental and Stem Cell Biology, Genomic Integrity, and Structural and Chemical Biology); Bridge Research (Cancer Biology and Experimental Pathology, Experimental Therapeutics, Immunology and Transplantation, and Imaging and Radiation Sciences); and Patient-Oriented Research (Clinical Research and Population Science Research). The programs are designed to optimize the use of a large patient population and an extensive, multi-disciplinary staff of clinical and laboratory-based investigators. MSK seeks to encourage the application of scientific discoveries in a way that advances the prevention, detection, diagnosis, and treatment of the many forms of cancer that are relevant to the population in our catchment area. Scientific work in the 10 research programs depends on services provided by 26 core facilities. We are requesting funding from the Cancer Center Support Grant (CCSG) for 20 of these core facilities. Over the next five years, MSK will continue to enhance its clinical and research facilities and its research and training programs in emerging research areas. Support is requested to provide developmental funding for the support of newly recruited investigators in computational biology, to support cross-disciplinary pilot projects in population science research, and to support the core facilities. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=10319494

Related SciGraph Publications

  • 2022-09-22. Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors in MODERN PATHOLOGY
  • 2022-09-22. Characteristics of Cancer Hospitals with Written Language Access Policies in JOURNAL OF IMMIGRANT AND MINORITY HEALTH
  • 2022-09-17. Sensitisation of cancer cells to radiotherapy by serine and glycine starvation in BRITISH JOURNAL OF CANCER
  • 2022-09-14. Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study in BLOOD CANCER JOURNAL
  • 2022-09-13. Diverse cell-specific patterns of alternative polyadenylation in Drosophila in NATURE COMMUNICATIONS
  • 2022-09-10. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms in MODERN PATHOLOGY
  • 2022-09-09. Inferring meaningful change in quality of life with posterior predictive distribution: an alternative to standard error of measurement in QUALITY OF LIFE RESEARCH
  • 2022-09-09. In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response in NATURE COMMUNICATIONS
  • 2022-09-07. Pregnancy and childbirth outcomes in women with myeloproliferative neoplasms—a nationwide population-based study of 342 pregnancies in Sweden in LEUKEMIA
  • 2022-09-07. Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine in SCIENTIFIC REPORTS
  • 2022-09-07. Magnetic resonance imaging features and clinical course of malignant melanotic nerve sheath tumors: single institution experience over two decades in SKELETAL RADIOLOGY
  • 2022-09-07. High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer in NATURE COMMUNICATIONS
  • 2022-09-05. Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2022-09-02. Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2022-09-01. Cofactor-assisted dicing: insights from structural snapshots in CELL RESEARCH
  • 2022-09-01. MIRTH: Metabolite Imputation via Rank-Transformation and Harmonization in GENOME BIOLOGY
  • 2022-08-29. Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer in NATURE CANCER
  • 2022-08-26. ASO Visual Abstract: Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy in ANNALS OF SURGICAL ONCOLOGY
  • 2022-08-23. Robotic Versus Laparoscopic Left and Extended Left Hepatectomy: An International Multicenter Study Propensity Score-Matched Analysis in ANNALS OF SURGICAL ONCOLOGY
  • 2022-08-23. Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA in NATURE COMMUNICATIONS
  • 2022-08-23. The KRYSTAL-1 study of adagrasib — a new trial for KRASG12C-mutated non-small-cell lung cancer in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2022-08-23. ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance in NPJ BREAST CANCER
  • 2022-08-22. Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster in BLOOD CANCER JOURNAL
  • 2022-08-20. Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study in BREAST CANCER RESEARCH AND TREATMENT
  • 2022-08-19. YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma in ACTA NEUROPATHOLOGICA COMMUNICATIONS
  • 2022-08-18. Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group in BLOOD CANCER JOURNAL
  • 2022-08-17. Study protocol of a multiphase optimization strategy trial (MOST) for delivery of smoking cessation treatment in lung cancer screening settings in TRIALS
  • 2022-08-17. Ordered and deterministic cancer genome evolution after p53 loss in NATURE
  • 2022-08-17. ASO Visual Abstract: Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy in ANNALS OF SURGICAL ONCOLOGY
  • 2022-08-16. Counting the cost of public and philanthropic R&D funding: the case of olaparib in JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
  • 2022-08-16. Moving towards patient-reported outcomes in routine clinical practice: implementation lessons from the BREAST-Q in QUALITY OF LIFE RESEARCH
  • 2022-08-15. Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients in GENOME MEDICINE
  • 2022-08-15. Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer in NATURE MEDICINE
  • 2022-08-13. Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum in CURRENT ONCOLOGY REPORTS
  • 2022-08-11. Disparities in Primary Breast Cancer Stage at Presentation Among Hispanic Subgroups in ANNALS OF SURGICAL ONCOLOGY
  • 2022-08-11. Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy in NPJ BREAST CANCER
  • 2022-08-11. Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy in ANNALS OF SURGICAL ONCOLOGY
  • 2022-08-10. Phase I study of lurbinectedin in combination with weekly paclitaxel with or without bevacizumab in patients with advanced solid tumors in INVESTIGATIONAL NEW DRUGS
  • 2022-08-08. Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors in JOURNAL OF CANCER SURVIVORSHIP
  • 2022-08-08. Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells in NATURE BIOMEDICAL ENGINEERING
  • 2022-08-08. ASO Visual Abstract: Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial embolization: A Retrospective Study on Patterns, Treatments, and Prognosis in ANNALS OF SURGICAL ONCOLOGY
  • 2022-08-06. ASO Visual Abstract: Disparities in Primary-Stage Breast Cancer at Presentation Among Hispanic Subgroups in ANNALS OF SURGICAL ONCOLOGY
  • 2022-08-05. Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade in ANNALS OF SURGICAL ONCOLOGY
  • 2022-08-04. ASO Author Reflections: How Immunotherapy Could Change the Management of Responsive Solid Tumors in ANNALS OF SURGICAL ONCOLOGY
  • 2022-08-02. Distinctive roles of translesion polymerases DinB1 and DnaE2 in diversification of the mycobacterial genome through substitution and frameshift mutagenesis in NATURE COMMUNICATIONS
  • 2022-08-01. ASO Author Reflections: The Need for Disaggregated Study among Hispanic Populations in ANNALS OF SURGICAL ONCOLOGY
  • 2022-07-28. PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine in NATURE IMMUNOLOGY
  • 2022-07-28. A Pilot Group-Based Lifestyle Intervention to Promote Weight Loss Among Mexican Immigrants in JOURNAL OF COMMUNITY HEALTH
  • 2022-07-28. Escalating de-escalation in breast cancer treatment in BREAST CANCER RESEARCH AND TREATMENT
  • 2022-07-28. Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy? in ANNALS OF SURGICAL ONCOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": 383091488.0
        }, 
        "description": "ABSTRACT Memorial Sloan Kettering Cancer Center (MSK) is a free-standing NCI-designated Comprehensive Cancer Center dedicated to improving the standards of cancer treatment, prevention and control. MSK\u2019s research programs are grouped into three categories: Basic Research (Regulation of Cell Behavior, Developmental and Stem Cell Biology, Genomic Integrity, and Structural and Chemical Biology); Bridge Research (Cancer Biology and Experimental Pathology, Experimental Therapeutics, Immunology and Transplantation, and Imaging and Radiation Sciences); and Patient-Oriented Research (Clinical Research and Population Science Research). The programs are designed to optimize the use of a large patient population and an extensive, multi-disciplinary staff of clinical and laboratory-based investigators. MSK seeks to encourage the application of scientific discoveries in a way that advances the prevention, detection, diagnosis, and treatment of the many forms of cancer that are relevant to the population in our catchment area. Scientific work in the 10 research programs depends on services provided by 26 core facilities. We are requesting funding from the Cancer Center Support Grant (CCSG) for 20 of these core facilities. Over the next five years, MSK will continue to enhance its clinical and research facilities and its research and training programs in emerging research areas. Support is requested to provide developmental funding for the support of newly recruited investigators in computational biology, to support cross-disciplinary pilot projects in population science research, and to support the core facilities.", 
        "endDate": "2023-12-31", 
        "funder": {
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2438793", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "grant.2438793"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "P30CA008748"
            ]
          }
        ], 
        "keywords": [
          "Memorial Sloan-Kettering Cancer Center", 
          "Cancer Center", 
          "comprehensive cancer center", 
          "larger patient population", 
          "forms of cancer", 
          "patient population", 
          "multi-disciplinary staff", 
          "cancer treatment", 
          "prevention", 
          "Support Grant", 
          "treatment", 
          "training program", 
          "investigators", 
          "patients", 
          "population", 
          "cancer", 
          "diagnosis", 
          "basic research", 
          "center", 
          "NCI", 
          "program", 
          "pilot project", 
          "years", 
          "staff", 
          "catchment area", 
          "facilities", 
          "core facilities", 
          "support", 
          "control", 
          "funding", 
          "research program", 
          "developmental funding", 
          "area", 
          "research", 
          "use", 
          "categories", 
          "biology", 
          "detection", 
          "services", 
          "discovery", 
          "standards", 
          "grants", 
          "research facility", 
          "form", 
          "scientific discovery", 
          "science research", 
          "bridge research", 
          "way", 
          "project", 
          "work", 
          "research area", 
          "applications", 
          "scientific work", 
          "computational biology"
        ], 
        "name": "Cancer Center Support Grant", 
        "recipient": [
          {
            "id": "http://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/None", 
              "name": "SLOAN-KETTERING INST CAN RESEARCH", 
              "type": "Organization"
            }, 
            "familyName": "THOMPSON", 
            "givenName": "CRAIG B", 
            "id": "sg:person.010620654227.65", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.010620654227.65", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2438793"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2022-10-01T07:02", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/grant/grant_39.jsonl", 
        "startDate": "1977-01-01", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=10319494"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2438793'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2438793'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2438793'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2438793'


     

    This table displays all metadata directly associated to this object as RDF triples.

    98 TRIPLES      18 PREDICATES      74 URIs      66 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2438793 schema:about anzsrc-for:06
    2 schema:amount Nbd0a0859bbac4dbe87b9a011a0208379
    3 schema:description ABSTRACT Memorial Sloan Kettering Cancer Center (MSK) is a free-standing NCI-designated Comprehensive Cancer Center dedicated to improving the standards of cancer treatment, prevention and control. MSK’s research programs are grouped into three categories: Basic Research (Regulation of Cell Behavior, Developmental and Stem Cell Biology, Genomic Integrity, and Structural and Chemical Biology); Bridge Research (Cancer Biology and Experimental Pathology, Experimental Therapeutics, Immunology and Transplantation, and Imaging and Radiation Sciences); and Patient-Oriented Research (Clinical Research and Population Science Research). The programs are designed to optimize the use of a large patient population and an extensive, multi-disciplinary staff of clinical and laboratory-based investigators. MSK seeks to encourage the application of scientific discoveries in a way that advances the prevention, detection, diagnosis, and treatment of the many forms of cancer that are relevant to the population in our catchment area. Scientific work in the 10 research programs depends on services provided by 26 core facilities. We are requesting funding from the Cancer Center Support Grant (CCSG) for 20 of these core facilities. Over the next five years, MSK will continue to enhance its clinical and research facilities and its research and training programs in emerging research areas. Support is requested to provide developmental funding for the support of newly recruited investigators in computational biology, to support cross-disciplinary pilot projects in population science research, and to support the core facilities.
    4 schema:endDate 2023-12-31
    5 schema:funder grid-institutes:grid.48336.3a
    6 schema:identifier N36bffbf88f624a2baa0c69fba169e25e
    7 Ne9f913fe653b4732912fceb1064c8e60
    8 schema:keywords Cancer Center
    9 Memorial Sloan-Kettering Cancer Center
    10 NCI
    11 Support Grant
    12 applications
    13 area
    14 basic research
    15 biology
    16 bridge research
    17 cancer
    18 cancer treatment
    19 catchment area
    20 categories
    21 center
    22 comprehensive cancer center
    23 computational biology
    24 control
    25 core facilities
    26 detection
    27 developmental funding
    28 diagnosis
    29 discovery
    30 facilities
    31 form
    32 forms of cancer
    33 funding
    34 grants
    35 investigators
    36 larger patient population
    37 multi-disciplinary staff
    38 patient population
    39 patients
    40 pilot project
    41 population
    42 prevention
    43 program
    44 project
    45 research
    46 research area
    47 research facility
    48 research program
    49 science research
    50 scientific discovery
    51 scientific work
    52 services
    53 staff
    54 standards
    55 support
    56 training program
    57 treatment
    58 use
    59 way
    60 work
    61 years
    62 schema:name Cancer Center Support Grant
    63 schema:recipient Ne7517d60a116489689379024ac20eaac
    64 sg:person.010620654227.65
    65 grid-institutes:grid.51462.34
    66 schema:sameAs https://app.dimensions.ai/details/grant/grant.2438793
    67 schema:sdDatePublished 2022-10-01T07:02
    68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    69 schema:sdPublisher N60d6d8e252ff46a3ab1db45414cf6020
    70 schema:startDate 1977-01-01
    71 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=10319494
    72 sgo:license sg:explorer/license/
    73 sgo:sdDataset grants
    74 rdf:type schema:MonetaryGrant
    75 N36bffbf88f624a2baa0c69fba169e25e schema:name dimensions_id
    76 schema:value grant.2438793
    77 rdf:type schema:PropertyValue
    78 N60d6d8e252ff46a3ab1db45414cf6020 schema:name Springer Nature - SN SciGraph project
    79 rdf:type schema:Organization
    80 Nbd0a0859bbac4dbe87b9a011a0208379 schema:currency USD
    81 schema:value 383091488.0
    82 rdf:type schema:MonetaryAmount
    83 Ne7517d60a116489689379024ac20eaac schema:member sg:person.010620654227.65
    84 schema:roleName PI
    85 rdf:type schema:Role
    86 Ne9f913fe653b4732912fceb1064c8e60 schema:name nih_id
    87 schema:value P30CA008748
    88 rdf:type schema:PropertyValue
    89 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    90 rdf:type schema:DefinedTerm
    91 sg:person.010620654227.65 schema:affiliation grid-institutes:None
    92 schema:familyName THOMPSON
    93 schema:givenName CRAIG B
    94 rdf:type schema:Person
    95 grid-institutes:None schema:name SLOAN-KETTERING INST CAN RESEARCH
    96 rdf:type schema:Organization
    97 grid-institutes:grid.48336.3a schema:Organization
    98 grid-institutes:grid.51462.34 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...